Measuring transparency to improve good governance in the public pharmaceutical sector: Oman / World Health Organization. Regional Office for the Eastern Mediterranean
Tác giả : World Health Organization. Regional Office for the Eastern Mediterranean
Nhà xuất bản : World Health Organization. Regional Office for the Eastern Mediterranean
Năm xuất bản : 2016
ISBN : 978-92-9022-128-9
Chủ đề : 1. Drug Approval -- organization and administration. 2. Drug Evaluation. 3. Government Regulation. 4. Pharmaceutical Services -- standards. 5. Public Sector. 6. Publications.
Thông tin chi tiết
Tóm tắt : | 86 p. This report presents the findings of the first phase of the national Good Governance for Medicines programme. In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
Tổ chức y tế thế giới |
|
https://iris.who.int/handle/10665/208821 |